Related Experiment Video
Updated: Dec 19, 2025

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Risk of Iodine Deficiency in Extremely Low Gestational Age Newborns on Parenteral Nutrition
Neelakanta Kanike1, Sharon Groh-Wargo1, Megan Thomas2
1Department of Pediatrics, Division of Neonatology, Case Western Reserve University, Metro Health Medical Center, Rm C.G75, 2500 MetroHealth Drive, Cleveland, OH 44109, USA.
Insights
Iodine deficiency is common in pregnant women and extremely low gestational age newborns (ELGAN). ELGAN on parenteral nutrition (PN) are at risk for hypothyroidism, highlighting the need for iodine supplementation.
Area of Science:
- Endocrinology
- Neonatology
- Nutritional Science
Background:
- Iodine is essential for thyroid hormone synthesis, crucial for neurodevelopment.
- Routine iodine status assessment is lacking in pregnant women and newborns.
- Extremely Low Gestational Age Newborns (ELGAN) on parenteral nutrition (PN) do not receive iodine supplementation.
Purpose of the Study:
- To assess iodine status and thyroid function in mother-infant dyads.
- To evaluate iodine levels in breast milk and PN.
- To correlate iodine status with thyroid function in ELGAN.
Main Methods:
- Measured urine iodine and thyroid function tests (free T4, TSH, thyroglobulin) in 50 mother-infant dyads.
- Sampled at birth, 1 week, 1, 2, 3 months, and near discharge.
- Analyzed iodine content in milk and PN; correlated maternal/neonatal iodine with thyroid function.
Main Results:
- 64% of mothers were iodine deficient at delivery; ELGAN showed transiently high iodine levels post-exposure.
- ELGAN on PN developed iodine deficiency and elevated thyroglobulin by 1 month.
- Iodine levels improved with enteral feeding by 2 months; PN-exposed ELGAN had significantly higher iodine than full-term infants.
Conclusions:
- Iodine deficiency is prevalent in pregnant women and ELGAN.
- ELGAN on PN are at high risk for iodine deficiency and subsequent hypothyroidism.
- Consideration of iodine supplementation during pregnancy and postnatally is recommended.
Abstract:
Iodine is an essential component of thyroid hormones, which play a critical role in neurodevelopment. The iodine status of pregnant women and their newborns is not checked routinely. Extremely Low Gestational Age Newborns do not receive Iodine supplementation while on parenteral nutrition (PN). We measured urine iodine levels and thyroid function tests in 50 mother-infant dyads at birth, at 1 week, 1, 2, 3 months and near discharge. We correlated maternal and neonatal urine iodine levels with thyroid functions and measured iodine levels in milk and PN. In our study, 64% of mothers were iodine deficient at the time of delivery, their free T4 levels were 0.48 (0.41-0.54) ng/dL with normal thyroid-stimulating hormone (TSH). Iodine levels were thirty-fold higher in extremely low gestational age newborns (ELGAN) exposed to iodine comparing to full terms (p < 0.001), but this effect lasted <1 week. At 1 month of age, ELGAN on PN developed iodine deficiency (p = 0.017) and had high thyroglobulin levels of 187 (156-271) ng/mL. Iodine levels improved with enteral feeds by 2 months of age (p = 0.01). Iodine deficiency is prevalent among pregnant women and ELGAN; in particular, those on PN are at risk of hypothyroidism. Iodine supplementation during pregnancy and postnatally should be considered to avoid iodine deficiency.
More Related Videos
Related Concept Videos
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Radiological Investigation I: X-ray and CT
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Factors Affecting Drug Response: Overview

